Sony Group Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Sony Group Corp files with the SEC in its annual reports.

In JPY millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	8,105,712	7,603,250	8,543,982	8,665,687	8,259,885	8,999,360	9,921,513	10,974,373	13,020,768	12,957,064
Cost of revenue	5,166,894	4,753,010	5,188,259	5,150,750	4,753,174	5,072,596	5,845,804	7,174,723	8,089,317	8,504,810
Gross profit	2,938,818	2,850,240	3,355,723	3,514,937	3,506,711	3,926,764	4,075,709	3,799,650	4,931,451	4,452,254
Research and development	468,183	447,456	458,518	481,202	499,290	525,175	618,368	735,698	742,772	734,578
Selling, general and administrative	1,691,930	1,505,956	1,583,197	1,576,825	1,502,625	1,469,955	1,588,473	1,969,170	2,156,156	2,256,829
Operating income	294,197	288,702	734,860	894,235	845,459	971,865	1,202,339	1,302,389	1,208,831	1,407,163
Interest expense	25,286	14,544	13,566	12,467	11,090	12,185	104,140	58,951	65,766	72,461
Interest income	12,455	11,459	19,784	21,618	19,278	10,457	19,304	31,058	125,597	139,024
Pre-tax income	304,504	251,619	699,049	1,011,648	799,450	1,192,370	1,117,503	1,274,496	1,268,662	1,473,726
Income tax	94,789	124,058	151,770	45,098	177,190	995	229,097	262,723	288,168	313,839
Net income to minority interests	61,924	54,272	56,485	50,279	40,069	19,599	6,228	6,496	9,921	18,287
Net income	147,791	73,289	490,794	916,271	582,191	1,171,776	882,178	1,005,277	970,573	1,141,600
EBITDA	691,288	615,750	1,096,304	1,268,261	1,262,101	1,362,558	2,106,809	2,306,979	2,353,812	2,560,150
EPS, basic	23.88	11.61	77.66	144.68	94.33	190.46	142.37	162.71	157.66	188.71
EPS, diluted	23.50	11.38	75.95	141.55	92.25	187.38	141.03	161.97	157.14	187.92
Shares, diluted (weighted)	6,289	6,442	6,462	6,473	6,311	6,253
Dividend per share	4.00	4.00	5.50	7.00	9.00	11.00

Balance sheet

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	983,612	960,142	1,586,329	1,470,073	1,512,357	1,786,982	2,049,636	1,480,900	1,907,113	2,980,956
Short-term investments	946,397	1,051,441	1,176,601	1,324,538	1,847,772	2,902,438
Inventory	683,146	640,835	692,937	653,278	589,969	637,391	874,007	1,468,042	1,518,644	1,310,770
Other current assets	482,982	525,861	516,744	509,301	594,021	538,540
Total current assets	4,196,727	4,355,722	5,176,096	5,246,612	5,735,145	7,218,744	5,535,208	5,722,532	6,776,806	7,454,988
Property, plant and equipment	820,818	758,199	739,470	777,053	908,644	985,434	1,113,213	1,344,864	1,522,640	1,513,660
Lease right-of-use assets					359,510	337,322	413,430	478,063	503,395	521,685
Goodwill	606,290	522,538	530,492	768,552	783,888	827,149	952,895	1,275,112	1,487,100	1,508,721
Intangible assets	615,754	584,185	527,168	917,966	906,310	996,305
Long-term investments	9,234,083	10,111,793	10,756,058	11,724,651	12,734,132	14,263,995
Other non-current assets	2,120,534	2,097,914	2,066,269	2,824,265	3,234,086	3,427,241
Total assets	16,673,390	17,660,556	19,065,538	20,981,586	23,039,343	26,354,840	30,480,967	31,154,095	34,107,490	35,293,173
Accounts payable	550,964	539,900	468,550	492,124	380,810	599,569	1,843,242	1,866,101	2,064,905	2,100,144
Accrued liabilities	1,367,115	1,394,758	1,514,433	1,693,048	1,630,197	1,756,833
Short-term debt	187,668	53,424	225,522	172,461	29,807	131,699	1,976,553	1,914,934	1,812,605	1,843,959
Total current liabilities	4,830,750	5,221,739	5,620,541	6,079,815	6,240,443	7,815,424	8,760,150	9,318,409	10,192,045	10,688,788
Long-term debt	556,605	681,462	623,451	568,372	634,966	773,294
Lease liabilities					314,836	290,259
Other non-current liabilities	330,302	314,771	278,338	281,382	289,285	294,302
Total liabilities	13,541,502	14,513,076	15,409,171	16,536,095	18,242,041	20,725,185	23,283,718	24,496,945	26,351,385	26,783,022
Total debt	744,273	734,886	848,973	740,833	664,773	1,259,042	1,375,055	1,955,638	2,275,828	2,354,287
Paid-in capital	1,325,719	1,275,337	1,282,577	1,266,874	1,289,719	1,486,721
Retained earnings	936,331	984,368	1,440,387	2,320,586	2,768,856	3,857,152	3,760,763	5,092,442	6,002,407	6,678,168
Treasury stock	-4,259	-4,335	-4,530	-104,704	-232,503	-124,228
Other comprehensive income	-653,318	-618,769	-616,746	-610,670	-580,980	-524,020
Shareholders' equity	2,463,340	2,497,246	2,967,366	3,746,377	4,125,306	5,575,839	7,144,471	6,598,537	7,587,177	8,179,745
Minority interests	661,070	638,176	679,791	690,313	664,229	45,637	52,778	58,613	168,928	330,406
Total equity	3,124,410	3,135,422	3,647,157	4,436,690	4,789,535	5,621,476	7,197,249	6,657,150	7,756,105	8,510,151
Total liabilities and equity	16,673,390	17,660,556	19,065,538	20,981,586	23,039,343	26,354,840	30,480,967	31,154,095	34,107,490	35,293,173

Cash flow statement

	FY2015	FY2016	FY2017	FY2018	FY2019	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	209,715	127,561	547,279	966,550	622,260	1,191,375	888,406	1,011,773	980,494	1,159,887
Depreciation and amortization	397,091	327,048	361,444	374,026	416,642	390,693	904,470	1,004,590	1,144,981	1,152,987
Stock-based compensation	1,944	2,737	5,249	5,499	5,958	8,927
Deferred income tax	211	23,798	24,085	-121,650	4,799	-153,427
Change in inventory	-57,804	11,199	-51,508	30,455	40,315	-57,007
Change in payables	-49,525	-1,386	-87,939	18,534	-91,435	211,939
Cash from operations	749,089	807,530	1,253,971	1,258,738	1,349,745	1,350,150	1,233,643	314,691	1,373,213	2,321,675
Capital expenditures	-375,411	-333,509	-262,989	-312,644	-439,761	-512,239
Acquisitions				-244,197
Cash from investing	-1,030,403	-1,255,022	-823,068	-1,307,445	-1,352,278	-1,781,516	-728,780	-1,052,664	-818,886	-930,120
Stock issued	301,708	2,730	7,129	12,757	7,560	12,430
Share buybacks		-114	-198	-100,177	-200,211	-366	-88,624	-99,248	-202,974	-285,548
Dividends paid	-12,751	-25,301	-28,490	-38,067	-49,574	-61,288	-74,342	-86,568	-98,620	-115,253
Cash from financing	380,122	452,302	246,456	-122,884	65,658	666,967	-336,578	84,300	-210,709	-298,243
Exchange rate effect	-64,609	-31,061	-53,044	52,465	-21,643	36,668	94,369	84,937	82,595	-19,469
Net change in cash	34,199	-26,251	624,315	-119,126	41,482	272,269	262,654	-568,736	426,213	1,073,843
Free cash flow	373,678	474,021	990,982	946,094	909,984	837,911
Interest paid	26,166	13,877	12,169	10,882	10,000	8,491
Income taxes paid	138,770	106,054	101,092	210,499	216,922	119,084

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.

Profitability

Metric	Value	How it is calculated
Gross margin	34.4%	Gross profit / revenue.
Operating margin	10.9%	Operating income / revenue.
EBITDA margin	19.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.4%	Pre-tax income / revenue.
Net margin	8.8%	Net income / revenue.
Operating cash flow margin	17.9%	Cash from operations / revenue.
Effective tax rate	21.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.3%	Net income / average total assets.
Return on invested capital (ROIC)	14.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	5.7%	Research and development expense / revenue.
SG&A / revenue	17.4%	Selling, general and administrative expense / revenue.
D&A / revenue	8.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-0.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-9.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	5.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	10.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	8.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	6.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	15.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	17.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	9.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	14.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	19.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	10.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	69.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	23.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	11.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	3.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.70x	Current assets / current liabilities.
Quick ratio	0.28x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.28x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.29x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	6.7%	Total debt / total assets.
Liabilities / assets	75.9%	Total liabilities / total assets.
Net debt	-¥626.67B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	19.4x	Operating income / interest expense.
Working capital	-¥3.23T	Current assets - current liabilities.
Goodwill and intangibles / assets	4.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	¥6.67T	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.37x	Revenue / average total assets.
Fixed asset turnover	8.53x	Revenue / average property, plant and equipment.
Inventory turnover	6.01x	Cost of revenue / average inventory.
Days inventory	61 days	365 x average inventory / cost of revenue.
Days payables	89 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	¥187.92	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	¥188.71	Net income per basic share, as reported (split-adjusted).
Payout ratio	10.1%	Dividends paid / net income, when net income is positive.

What was Sony Group Corp's revenue in fiscal 2025?

Sony Group Corp reported revenue of ¥12.96T for fiscal 2025, 0.5% lower than the year before.

Was Sony Group Corp profitable in fiscal 2025?

Yes. Net income was ¥1.14T, a net margin of 8.8%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Sony Group Corp